ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum

ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum
复制标题

DOI:
10.1016/j.vaccine.2019.02.071
复制
发表时间:
2019-04-03
期刊:
影响因子:
5.5
通讯作者:
Long, Carole A.
Long, Carole A.
中科院分区:
医学3区
文献类型:
--
作者:
Miura, Kazutoyo;Deng, Bingbing;Long, Carole A.

文献摘要

被引文献

相似文献

标准膜喂养试验(SMFA)是一种功能性试验,已用于为恶性疟原虫疟疾传播阻断疫苗(TBV)的开发提供信息。对于Pfs 230,TBV发展的主要靶抗原,一些研究已经测试了连续稀释的单一抗Pfs 230多克隆或单克隆抗体(每个研究一种抗体),并显示出剂量依赖性反应。此外,已有报道称,在补体存在下,抗Pfs 230多克隆和单克隆抗体的SMFA活性增强。然而,尚未对多个样本进行分析,并通过SMFA评价了抗Pfs 230抗体滴度、IgG亚类谱和亲合力对降低传播活性(TRA)的影响。在本报告中,评估了来自5项不同小鼠免疫研究的共计39种独特抗Pfs 230 IgG的ELISA单位(EU)、IgG 2/IgG 1比和亲合力(ELISA法)以及功能性(%传播减少活性,%TRA)(SMFA法)。使用Alhydrogel或Montanide ISA 720佐剂,用单独的Pfs 230、与CRM 197缀合的Pfs 230或未缀合的Pfs 230和CRM 197蛋白的混合物免疫小鼠。在所有研究中,Pfs 230抗原均来自同一来源。对于抗Pfs 230 IgG,EU和%TRA之间存在显著相关性(通过斯皮尔曼秩检验,p < 0.0001)。值得注意的是,多元线性回归分析显示,在调整EU后,IgG 2/IgG 1比值和亲合力均显著影响%TRA(p = 0.003至p = 0.014,取决于模型)。结果表明,除了抗体滴度,IgG 2/IgG 1比和亲合力应分别进行评估,以预测未来疫苗开发的抗Pfs 230抗体的生物活性。(C)2019由Elsevier Ltd.出版
The standard membrane-feeding assay (SMFA) is a functional assay that has been used to inform the development of transmission-blocking vaccines (TBV) against Plasmodium falciparum malaria. For Pfs230, a lead target antigen for TBV development, a few studies have tested either a single anti-Pfs230 poly-clonal or monoclonal antibody (one antibody per study) at serial dilutions and showed a dose-dependent response. Further, there have been reports that the SMFA activity of anti-Pfs230 poly-clonal and monoclonal antibodies were enhanced in the presence of complement. However, no analysis has been performed with multiple samples, and the impact of anti-Pfs230 antibody titers, IgG subclass profile and avidity were evaluated together in relation to transmission-reducing activity (TRA) by SMFA. In this report, a total of 39 unique anti-Pfs230 IgGs from five different mouse immunization studies were assessed for their ELISA units (EU), IgG2/IgG1 ratio and avidity by ELISA, and the functionality (% transmission-reducing activity, %TRA) by SMFA. The mice were immunized with Pfs230 alone, Pfs230 conjugated to CRM197, or a mixture of unconjugated Pfs230 and CRM 197 proteins using Alhydrogel or Montanide ISA720 adjuvants. In all studies, the Pfs230 antigen was from the same source. There was a significant correlation between EU and %TRA (p < 0.0001 by a Spearman rank test) for the anti-Pfs230 lgGs. Notably, multiple linear regression analyses showed that both IgG2/IgG1 ratio and avidity significantly affected %TRA (p = 0.003 to p = 0.014, depending on the models) after adjusting for EU. The results suggest that in addition to antibody titers, IgG2/IgG1 ratio and avidity should each be evaluated to predict the biological activity of anti-Pfs230 antibodies for future vaccine development. (C) 2019 Published by Elsevier Ltd.